Cytek BiosciencesvsThermo Fisher Scientific

CTKB and TMO stock compared: price, dividend, valuation and results, from SEC filings.

CTKB

Cytek Biosciences, Inc.

$5.84

Value $751M

+5.80%
CTKB's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Cytek Biosciences (CTKB) has a market value of $751M and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, CTKB moved +21.4% and TMO +19.5%. Dividend yield: CTKB none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CTKB$751M

    TMO$260B

    TMO is 346 times CTKB

  • Revenue, 12 months

    CTKB$208M

    TMO$47.4B

    TMO is 228 times CTKB

  • Net income, 12 months

    CTKB-$81M

    TMO$7.1B

  • Operating margin

    CTKB-21.1%

    TMO17.9%

    39.0 points apart

  • ROIC

    CTKB-10.3%

    TMO8.2%

    18.4 points apart

  • P/E

    CTKB–

    TMO36.8

  • Dividend yield

    CTKB0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    CTKB-75.3%

    TMO+11.8%

    87.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CTKB-75.3%

TMO+11.8%

5010020222023202420252026
Returns by period
PeriodCTKBWith dividendsTMOWith dividends
1 year since November 12, 2025+21.4%Price +21.4%+19.5%Price +19.1%
3 years since November 13, 2023+17.7%+5.6% a yearPrice +17.7%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-75.3%-24.4% a yearPrice -75.3%+11.8%+2.3% a yearPrice +10.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CTKBCytek BiosciencesTMOThermo Fisher Scientific

Valuation

CTKBTMO
Valuation
Price$5.84$700.22
Market value$751M$260B
Enterprise value (EV)$684M$295B
P/E–36.8
P/E, 5-year median–32.7
P/B2.34.8
EV/EBIT–34.9
Free cash flow yield–2.9%

Results and growth

CTKBTMO
Results and growth
Revenue, 12 months$208M$47.4B
Net income, 12 months-$81M$7.1B
Free cash flow, 12 months-$13M$7.6B
Earnings per share, 12 months-$0.63$18.96
Revenue growth, year on year0.5%3.9%
Revenue growth a year, past+16.8%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

CTKBTMO
Margins and returns on capital
Gross margin54.8%–
Operating margin-21.1%17.9%
Net margin-39.1%14.9%
ROIC-10.3%8.2%
ROE-24.0%13.4%

Balance sheet

CTKBTMO
Balance sheet
Cash$67M$6.1B
Total debt$16M$41.4B
Net debt / EBITDA–3.7
Interest cover-562.6×5.5×

Dividends and buybacks

CTKBTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield2.0%1.2%
Shareholder yield2.0%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CTKB or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Cytek Biosciences or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 346.5 times Cytek Biosciences ($751M), at today's prices.

How did CTKB and TMO stock do over the last 5 years?

Since November 12, 2021, CTKB's price moved -75.3% and TMO's +10.2%. With dividends: CTKB -75.3% (-24.4% a year), TMO +11.8% (+2.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, CTKB or TMO?

The dividend yield at today's price is none for Cytek Biosciences and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Cytek Biosciences or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -39.1% for Cytek Biosciences and 14.9% for Thermo Fisher Scientific, and the operating margin -21.1% and 17.9%. Revenue was $208M and $47.4B.

Which is the better investment, Cytek Biosciences or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.